Toronto, Ontario--(Newsfile Corp. - May 17, 2024) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company focused on the production and distribution of health and wellness products derived from the Amanita Muscaria mushroom, announces that it has granted 3,800,000 Stock Options to directors, officers, Consultants and employees in accordance with the terms of the Stock Option Plan. The Stock Options granted will the vest after four months. The Common Shares underlying the Stock Options are subject to a four month hold period in accordance with the policies of the Canadian Securities Exchange (the "CSE").

Toronto, Ontario--(Newsfile Corp. - May 1, 2024) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched Wellness"), a life sciences company focused on the production and distribution of health and wellness products derived from the Amanita Muscaria mushroom, is pleased to announce that, further to its press releases dated May 30, 2023 (the "May 30 Release") and June 12, 2023 (the "June 12 Release"), September 1, 2023 (the "September 1 Release"), September 5, 2023, January 17, 2024 and April 19, 2024 (the "April 19 Release"), it has closed the final tranche of its previously announced non-brokered private placement (the "Offering") effective April 30, 2024 (the "Tranche 2B Closing Date") for gross proceeds of US$2,500,000 ("Tranche 2B") upon satisfying the Tranche 2B closing conditions and receiving a closing notice. Capitalized terms not otherwise defined herein have the meanings attributed to them in the May 30 Release.